http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29590774

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 232
issn 1528-4336
1945-5771
issueIdentifier 4
pageRange 228-232
publicationName HIV Clinical Trials
startingPage 228
bibliographicCitation DeJesus E, Rockstroh JK, Lennox JL, Saag MS, Lazzarin A, Zhao J, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P; STARTMRK Investigators. Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. HIV Clin Trials. 2012 Jul;13(4):228–32. doi: 10.1310/hct1304-228. PMID: 22849964.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9575ac72fc4c9a01da1c28946cbfa4c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5221c03971dea21e3c0575486aca4a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da5e056d2b5d44c5bda8f6fda1145ace
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f42f4003db118b50109a93ccfa208956
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42ede84b93bf53921c0f5bcaaaf212f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae0a145e50e4e9dd33e91ab1b272cc7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6054f160d0c64896f44de790325f3c6e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_217d4667b5ae747fcb927d00f7f4b8d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5372ba07407fcac576308382670fbc16
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dd74bc7621df8552025aeef4ad0c82f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7111e79505c28f0c80b8b3ba9eed8148
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d187c8b326c7f4478f981d024ef964b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b6f8733f4b133e2707025c031a9298
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f39c4231cf4b484cc5ed524413c97ed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbc15749408bd07999c74766e5b57474
date 201208
identifier https://doi.org/10.1310/hct1304-228
https://pubmed.ncbi.nlm.nih.gov/22849964
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26735
https://portal.issn.org/resource/ISSN/1945-5771
https://portal.issn.org/resource/ISSN/1528-4336
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK
discusses http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0461882
http://id.nlm.nih.gov/mesh/M0571031
http://id.nlm.nih.gov/mesh/M0000347
http://id.nlm.nih.gov/mesh/M0018278
http://id.nlm.nih.gov/mesh/M0005491
http://id.nlm.nih.gov/mesh/M000604085
http://id.nlm.nih.gov/mesh/M0028839
http://id.nlm.nih.gov/mesh/M0258297
http://id.nlm.nih.gov/mesh/M0000724
http://id.nlm.nih.gov/mesh/M0254881
http://id.nlm.nih.gov/mesh/M0337569
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015497
http://id.nlm.nih.gov/mesh/D000163Q000188
http://id.nlm.nih.gov/mesh/D019380Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000068698
http://id.nlm.nih.gov/mesh/D000068679
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D003521
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000480
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D011760Q000008
http://id.nlm.nih.gov/mesh/D003841Q000031
http://id.nlm.nih.gov/mesh/D000163Q000821
http://id.nlm.nih.gov/mesh/D018791
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D048588Q000008
http://id.nlm.nih.gov/mesh/D000225Q000031
http://id.nlm.nih.gov/mesh/D000163Q000276
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000225Q000008
http://id.nlm.nih.gov/mesh/D000068898
http://id.nlm.nih.gov/mesh/D024882
http://id.nlm.nih.gov/mesh/D063065Q000008
http://id.nlm.nih.gov/mesh/D003841Q000008
http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54671008
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11954236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129727356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247696300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233080

Total number of triples: 83.